We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This manuscript addresses a critical topic: navigating complexities of conducting clinical trials during a pandemic. Central to this discussion is engaging communities to ensure diverse participation. The manuscript elucidates deliberate strategies employed to recruit minority communities with poor social drivers of health for participation in COVID-19 trials. The paper adopts a descriptive approach, eschewing analysis of data-driven efficacy of these efforts, and instead provides a comprehensive account of strategies utilized. The Accelerate COVID-19 Treatment Interventions and Vaccines (ACTIV) public–private partnership launched early in the COVID-19 pandemic to develop clinical trials to advance SARS-CoV-2 treatments. In this paper, ACTIV investigators share challenges in conducting research during an evolving pandemic and approaches selected to engage communities when traditional strategies were infeasible. Lessons from this experience include importance of community representatives’ involvement early in study design and implementation and integration of well-developed public outreach and communication strategies with trial launch. Centralization and coordination of outreach will allow for efficient use of resources and the sharing of best practices. Insights gleaned from the ACTIV program, as outlined in this paper, shed light on effective strategies for involving communities in treatment trials amidst rapidly evolving public health emergencies. This underscores critical importance of community engagement initiatives well in advance of the pandemic.
This chapter discusses the various ways in which the relationship between kingship, violence and non-violence was conceptualised in ancient India during the period c. 500 BCE to 500 CE, both in general terms as well as in special relation to punishment and war. Examining a variety of textual, epigraphic and visual sources, it identifies a strong and enduring tension in ancient Indian political thought between the ethical principle of non-violence and the pragmatic need for the king to use force while discharging his duties. While non-violence was considered a laudable virtue, there was an acknowledgement, even in Buddhist and Jaina thought, that it was incompatible with political power. At the same time, a distinction was made between necessary force and force that was unnecessary, disproportionate, random or excessive. The former was accepted, the latter condemned. Moral and pragmatic arguments for the measured use of force were accompanied by a constant emphasis on self-control as a desirable royal virtue. By the middle of the first millennium a ‘classical’ model of kingship had emerged, wherein the king’s violence was legitimised and aestheticised. Nevertheless, a window for critiquing the potential and actual violence of the king remained.
Infectious polymyositis is an entity in which there is generalized muscle damage (rhabdomyolysis) caused by an infectious agent. The syndrome of rhabdomyolysis is characterized by elevated serum creatinine phosphokinase (CPK) concentrations and myoglobinuria leading to renal dysfunction. The muscle injury in rhabdomyolysis occurs in a generalized pattern and lacks a specific focus of abscess or infection as is seen in pyomyositis. The entity of pyomyositis is discussed in a separate chapter, Chapter 22, Deep Soft-Tissue Infections: Necrotizing Fasciitis and Gas Gangrene.
A variety of precipitating factors can lead to rhabdomyolysis. These include crush and compression injuries, drug and alcohol ingestion, metabolic and electrolyte disturbances, hypothermia and hyperthermia, and a variety of miscellaneous infections. This review focuses on infectious causes. It is important to distinguish rhabdomyolysis caused by a pathogen from that caused by sepsis, hypotension, or electrolyte imbalances that accompany a severe systemic infection.
VIRAL INFECTIONS
The wide spectrum of viral infections that have been reported to cause rhabdomyolysis are listed in Table 71.1. Influenza is the most common viral etiology reported to precipitate rhabdomyolysis, followed by human immunodeficiency virus (HIV) and enteroviral infection. The presenting symptoms in these patients include myalgias, weakness, muscle tenderness, and edema. Whether the association with influenza results primarily from a special predilection of the virus for the muscle tissue or frequent reporting of the association because of physician awareness and relative ease of diagnosis is unclear.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.